These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11424955)

  • 1. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system.
    Dluzen DE
    J Neurocytol; 2000; 29(5-6):387-99. PubMed ID: 11424955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Neuroscience; 2001; 103(2):385-94. PubMed ID: 11246153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.
    Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE
    Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice.
    Myers RE; Anderson LI; Dluzen DE
    Neuropharmacology; 2003 Apr; 44(5):624-32. PubMed ID: 12668048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
    Gajjar TM; Anderson LI; Dluzen DE
    J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.
    D'Astous M; Mickley KR; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2005; 82(2):111-20. PubMed ID: 16446547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen, testosterone, and methamphetamine toxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2006 Aug; 1074():282-94. PubMed ID: 17105924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system.
    Dluzen DE; McDermott JL; Anderson LI
    Neurotox Res; 2001 Jul; 3(3):291-300. PubMed ID: 15111254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
    Anderson LI; Leipheimer RE; Dluzen DE
    Neuroscience; 2005; 130(2):369-82. PubMed ID: 15664693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.
    Dluzen DE; McDermott JL; Anderson LI
    J Neuroendocrinol; 2001 Jul; 13(7):618-24. PubMed ID: 11442776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Brain Res; 2001 Feb; 892(1):63-9. PubMed ID: 11172749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons.
    Küppers E; Ivanova T; Karolczak M; Beyer C
    J Neurocytol; 2000; 29(5-6):375-85. PubMed ID: 11424954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B; Dluzen DE
    Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.
    Dluzen DE; McDermott JL; Liu B
    Neurotoxicol Teratol; 1996; 18(5):603-6. PubMed ID: 8888025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2004 Oct; 1025():205-20. PubMed ID: 15542719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.
    Dluzen D; Horstink M
    Endocrine; 2003 Jun; 21(1):67-75. PubMed ID: 12777705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.